HOPEWIND-ELECTRIC
28.5.2024 13:17:33 CEST | Business Wire | Press release
Hopewind (SHANGHAI STOCK EXCHANGE Code: 603063) has been officially nominated for the 2024 Smarter E award for its grid forming capable 385 kW utility-scale string inverter. Selected by jury for the Top 10 short list, makes Hopewind the only Chinese solar inverter manufacturer to reach the finals, highlighting the company's strong R&D capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240527117090/en/
Hopewind has been officially nominated for the 2024 Smarter E award (Photo: Business Wire)
“Our nomination for The Smarter E / Intersolar Award 2024 underlines our innovative nature that is core to our DNA,” said Wang Yao, Deputy General Manager of Hopewind.
Also in May, the Q2/2004 Global PV Market Outlook of Bloomberg New Energy Finance (BNEF) selected Hopewind to join its Tier 1 Photovoltaic Inverter Manufacturer list. “Ranking on BNEF’s prestigious Tier 1 list recognizes our financial and business strengths,” added Wang Yao, “and it confirms our strategy to delve deeper into the PV field, working on further innovations and breakthroughs to lead the development of global clean and renewable energy.”
As part of its innovation strategy, Hopewind officially joined the International Solar Energy Research Center Konstanz (ISC), one of world solar leading research institutes in April. Established in 2007, Hopewind was listed on the Shanghai Stock Exchange (Stock code: 603063) in 2017 as a leading innovator in the clean power generation industry, specializing in designing and producing renewable and electrical solutions, including wind power converters, PV inverters, battery storage systems (BESS), SVG, and industry drives with 150 GW+ shipments worldwide and GW production capacities.
Hopewind, participated in the Wingrid project, supported by the Horizon Europe 2020 and facilitated through the DNV Netherlands Laboratory. In 2023, Hopewind’s wind power converter received the world’s first grid forming certificate from DNV, with the 385kW inverter being selected as No.1 powerful solar string inverter by Solarbe Global since February, 2024.
Like in the Kubuqi Desert of Inner Mongolia, the seventh largest desert in China, an impressive transformation is taking place. Beneath over 10 kilometers of photovoltaic (PV) panels, herbs and pasture thrive, while chickens and goats roam and forage, bringing new life to the arid landscape.
The solar energy captured by these panels is converted into clean electricity by Hopewind 5,604 350kW inverters and fed into the power grid.
“This project showcases our corporate vision, which is to become a world-class provider of power conversion and control solutions, creating a more sustainable future for our world," Wang emphasized.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240527117090/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)4.5.2026 14:00:00 CEST | Press release
Investigational TAK-881 was comparable to established HYQVIA while also demonstrating reduced infusion volume and duration for PID patients Takeda (TSE:4502/NYSE:TAK) today announced that TAK-881-3001, a pivotal Phase 2/3 clinical trial in patients with Primary Immunodeficiency Disease (PID), met its primary endpoint, which demonstrated pharmacokinetic (PK) comparability between the investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) with Recombinant Human Hyaluronidase] and HYQVIA [Immune Globulin Infusion (Human) 10% with Recombinant Human Hyaluronidase]. Additionally, secondary endpoints showed that TAK-881, a SCIG 20% facilitated with hyaluronidase, demonstrated safety, efficacy and tolerability profiles comparable to HYQVIA, an established SCIG 10% facilitated with hyaluronidase. These findings support the potential of TAK-881 to deliver the required immunoglobulin (IG) dose for PID patients in half the volume of HYQVIA, reducing infusion duratio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom